Testing for drug-resistant fungus in blood or fluid
Part of Infections clinical trials.
This study is testing a new blood or fluid test that may find drug-resistant fungus in people with a weakened immune system who have a serious lung infection. The results could help doctors choose the right medicine faster.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- A CT scan of your lungs must show signs that could be a serious fungal infection.
- You must have had or be scheduled for a bronchoscopy to get a fluid sample from your lungs (within the last 48 hours or soon).
- You must be willing and able to give your consent to join the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how immune system problems relate to fungal infections, using medical records and lab tests on blood and tissue. It may help researchers understand the cause of these infections—especially for people with inherited immune conditions—and improve future care.
This study will use special scans to see how an inhaled antifungal medicine (amphotericin B) reaches the lungs in people with chronic pulmonary aspergillosis. The results may help doctors choose better treatments in the future.
This study looks for specific lab “biomarkers” in people with mucormycosis, a serious fungal infection. It compares results with people who have higher infection risk but no active infection, to help doctors diagnose and track this illness more accurately.
This study aims to detect invasive lung aspergillosis earlier by testing samples from your lungs and measuring specific lab markers. It may help doctors start the right antifungal treatment sooner when the infection is suspected.
This study looks at whether repeated PCR tests for a fungus called Aspergillus fumigatus (in blood or lung fluid) can help doctors track how well treatment is working for a serious lung infection called invasive aspergillosis. It is for people who already had a positive PCR test at diagnosis.
This study looks at samples from your lungs that contain Aspergillus fungus to understand why some fungi become resistant to antifungal medicines. By joining, you help researchers find better ways to treat these infections.
Hear when a new Invasive Aspergillosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.